ClariVest Asset Management’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.32M | Hold |
63,149
| – | – | 0.13% | 208 |
|
|
2024
Q2 | $1.32M | Buy |
63,149
+1,766
| +3% | +$36.9K | 0.13% | 208 |
|
|
2024
Q1 | $902K | Buy |
61,383
+115
| +0.2% | +$1.69K | 0.09% | 288 |
|
|
2023
Q4 | $632K | Buy |
61,268
+1,451
| +2% | +$15K | 0.04% | 337 |
|
|
2023
Q3 | $470K | Hold |
59,817
| – | – | 0.03% | 348 |
|
|
2023
Q2 | $597K | Buy |
59,817
+10,803
| +22% | +$108K | 0.03% | 327 |
|
|
2023
Q1 | $436K | Sell |
49,014
-86
| -0.2% | -$765 | 0.02% | 397 |
|
|
2022
Q4 | $539K | Sell |
49,100
-600
| -1% | -$6.59K | 0.03% | 375 |
|
|
2022
Q3 | $648K | Hold |
49,700
| – | – | 0.03% | 321 |
|
|
2022
Q2 | $630K | Buy |
+49,700
| New | +$630K | 0.03% | 348 |
|